Sbi Securities Co., Ltd. Pacira Bio Sciences, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 26 shares of PCRX stock, worth $607. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$607% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$187 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$123 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$76.3 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$52.8 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$46.6 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.07B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...